Does NALDEMEDINE Cause Malignant neoplasm progression? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Malignant neoplasm progression have been filed in association with NALDEMEDINE (SYMPROIC). This represents 4.0% of all adverse event reports for NALDEMEDINE.
27
Reports of Malignant neoplasm progression with NALDEMEDINE
4.0%
of all NALDEMEDINE reports
25
Deaths
3
Hospitalizations
How Dangerous Is Malignant neoplasm progression From NALDEMEDINE?
Of the 27 reports, 25 (92.6%) resulted in death, 3 (11.1%) required hospitalization, and 1 (3.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NALDEMEDINE. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does NALDEMEDINE Cause?
Diarrhoea (144)
Drug ineffective (92)
Abdominal pain (68)
Constipation (47)
Nausea (42)
Death (28)
Vomiting (27)
Drug withdrawal syndrome (24)
Neoplasm malignant (24)
Abdominal pain upper (20)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which NALDEMEDINE Alternatives Have Lower Malignant neoplasm progression Risk?
NALDEMEDINE vs NALMEFENE
NALDEMEDINE vs NALOXEGOL OXALATE
NALDEMEDINE vs NALOXONE
NALDEMEDINE vs NALOXONE\OXYCODONE
NALDEMEDINE vs NALOXONE\TILIDINE